WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

East Windsor is excited to welcome another pharmaceutical company Rising Pharmaceuticals to join the many other high-tech ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

The private equity business is reported to be looking for a buyer to take on its majority stake in Genetic Group, an Italian pharmaceutical contract manufacturing company. View on euronews ...

In the global pharmaceutical industry, there were two private equity deals announced in Q3 2024, worth a total value of $7.5m, according to GlobalData's Deals Database.

Royalty Pharma's Q3 results show growth driven by strong portfolio performance and acquisitions. See why we recommend a buy ...

Healthcare sector earnings report summary: 14 companies beat profit estimates, with major players like Viatris, Gilead ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...

The government's new Rs 500 crore scheme for the medical device industry will not only boost domestic manufacturing but also ...

In the global pharmaceutical industry, there were three private equity deals announced in Q3 2024, worth a total value of $4.2m, according to GlobalData's Deals Database.